Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SUMATRIPTAN SUCCINATE TABLETS safely and effectively. See full prescribing information for SUMATRIPTAN SUCCINATE TABLETS . SUMATRIPTAN SUCCINATE tablets, for oral use Initial U.S. Approval: 1992
Medication labelWhy this: Advisory · dailymed-prescription
Sumatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: •Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan succinate tablets, reconsider the diagnosis of migraine before sumatriptan succinate tablets are administered to treat any subsequent attacks. •Sumatriptan succinate tablets are not indicated for the prevention of migraine attacks. •Safety and effectiveness of sumatriptan succinate tablets have not been established for cluster headache.
- generic_name
- sumatriptan succinate
- product_names
- sumatriptan succinate
- ndc
- 71205-251, 62756-521, 71205-251-09
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en